5Hayashi N, Nakamori S,Okami J,et al. Asscciation between expression levels of CA 19-9 and N-acetylglucosaminee-beta; 1,3-galactosyltransferase 5gene in human pancreatic cancer tissun[ J ]. Pathobiology, 2003,71 ( 1 ): 26～34.
6Macchia V, Gargiulo M. Cyclic AMP-dependent secretion of CA 19-9 by LS174T human colon carcinoma cells[ J]. Oncol Rep, 2002, 9 (2): 387 ～391.
8Kim HJ,Lee KT, Kim SH,et al. Differential diagnosis of intrahepatic bile duct dilatation without demonstrable mass on ultrasonography or CT: Benign versus malignancy [ J ]. J Gastroenterol Hepatol.2003, 18 ( 11 ): 1 287 ～1292.
9Kokhanenko NIU, Ignashov AM, Varga EV, et al. Role of the tumor markers CA 19-9 and carcinoembryonic antigen(CEA)in diagnosis, treatment and prognosis of pancreatic cancer[J].Vopr 0nkol.2001,47(3) :294～ 297.
10Carpelan-Holmstrom M,Louhimo J,Stmman UH,et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers[J].Anticancer Res,2002,22(4) :2 311 ～ 2 316.
